SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NVS: Novartis AG -- Ignore unavailable to you. Want to Upgrade?


To: Tom Wilkes who wrote (14)1/25/2001 8:45:32 PM
From: Starlight  Read Replies (1) | Respond to of 116
 
Tom - I was able to get a partial fill on a limit order today for a little more NVS, but it could be some time before we see any real action in the stock. They don't get much publicity, but if the leukemia trials go well, that will change.

I,too, have held the stock a while, and it's been "dead in the water". Perhaps that will change before long.

(P.S. I also got Ciena at a low price -- not quite as good as yours, however.)

Betty



To: Tom Wilkes who wrote (14)1/26/2001 11:01:29 AM
From: Starlight  Respond to of 116
 
Bausch & Lomb could be takeover target -
biz.yahoo.com